We are live on
!
Find out more
FTDI
First Trust Direct Indexing Portfolio holdings
AUM
$1.87B
1-Year Est. Return
43.63%
This Fund
S&P 500
This Quarter
Est. Return
-1.88%
1 Year Est. Return
+43.63%
3 Year Est. Return
+69.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$875M
AUM Growth
-$23.4M
(-2.6%)
Cap. Flow
+$3.52M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
24.59%
Holding
745
New
35
Increased
366
Reduced
286
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.36M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.73M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.59M |
| 4 |
AbbVie
ABBV
|
+$1.03M |
| 5 |
Tesla
TSLA
|
+$789K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71M |
| 2 |
FITB
Fifth Third Bancorp
FITB
|
+$1.95M |
| 3 |
POSCO
PKX
|
+$1.58M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.3M |
| 5 |
Amazon
AMZN
|
+$999K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.72% |
| 2 | Financials | 15.02% |
| 3 | Healthcare | 12.2% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 8.26% |
Similar funds
CIM
BC
PRO
GFS
ECM
SEC
PP
GCAC
First Trust Direct Indexing's Q3 2023 Portfolio in Review
As of Q3 2023, First Trust Direct Indexing held 745 positions worth $875M, down 2.6% from $898M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
First Trust Direct Indexing's Q3 2023 filing shows 35 new, 366 increased, 286 reduced and 48 closed positions. Its largest new stake was Royalty Pharma: 16,044 shares worth $435K. The largest sale was Apple, an estimated $3.71M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- First Trust Direct Indexing's largest Q3 2023 buy was Royalty Pharma: 16,044 shares worth $435K.
- First Trust Direct Indexing added most to Microsoft in Q3 2023, an estimated $2.36M increase.
- First Trust Direct Indexing's biggest Q3 2023 reduction was Apple, cutting an estimated $3.71M.
- First Trust Direct Indexing fully exited BioMarin Pharmaceuticals in Q3 2023, selling an estimated $432K.
- First Trust Direct Indexing's ten largest holdings make up 25% of its $875M portfolio in Q3 2023.
- First Trust Direct Indexing opened 35 new positions and closed 48 in Q3 2023.
- First Trust Direct Indexing's portfolio value fell 2.6% quarter-over-quarter to $875M.
Based on First Trust Direct Indexing's 13F filing for Q3 2023, filed 30 Oct 2023.